newsfilter
← Latest News
GlobeNewswire·

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

  • Biofrontera Inc. (NASDAQ: BFRI) will report Q2 2026 financial results before market open on Thursday, August 13, 2026.
  • The company announced results for the quarter ended June 30, 2026.
  • Management will host a conference call & webcast at 10:00 a.m. Eastern Time on August 13, 2026, to discuss results & provide a business update.
  • Dial-in details include a U.S. / Canada toll-free number (1-877-877-1275) & an international number (1-412-858-5202).
  • The webcast is available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=a2Bp6alz.
  • Biofrontera is a U.S. specialty dermatology company commercializing Ameluz Gel 10% with the BF-RhodoLED lamp for photodynamic therapy of actinic keratosis.
  • The company has been a standalone, publicly traded entity since its 2021 IPO & operates Biofrontera Discovery GmbH in Germany.
  • Investor contact is Ben Shamsian at Lytham Partners (shamsian@lythampartners.com).